MICROBIX BIOSYSTEMS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.325 CAD | -2.99% |
|
-4.41% | -16.67% |
| Apr. 25 | Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology | MT |
| Mar. 27 | Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call |
Presenter SpeechDeborah Honig (Attendees)Good morning. Thanks for joining us with our first we...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Microbix Biosystems Inc. is a Canada-based life science company, which develops and commercializes biological and technological solutions for human health and wellbeing. The Company manufactures a wide range of critical biological materials for the global diagnostics industry, mainly antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. It operates through two segments: the development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and the development and commercialization of products or technologies such as Kinlytic. Its Kinlyti urokinase is a biologic thrombolytic drug used to treat blood clots.
Calendar
2024-05-08
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.325
CAD
Average target price
0.8
CAD
Spread / Average Target
+146.15%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.67% | 32.62M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- MBX Stock
- News Microbix Biosystems Inc.
- Transcript : Microbix Biosystems Inc., Q4 2023 Earnings Call, Jan 03, 2024
